Bristol-Myers Squibb buy Guggenheim
Start price
06.02.26
/
50%
€50.43
Target price
06.02.27
-
Performance (%)
1.45%
Price
25.05.26
€51.16
Summary
This prediction is currently active. The BUY prediction by Guggenheim shows slight gains of 1.45%. This prediction currently runs until 06.02.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | 4.047% | 4.047% |
| iShares Core DAX® | 4.127% | 4.543% |
| iShares Nasdaq 100 | 3.149% | 10.232% |
| iShares Nikkei 225® | 7.674% | 10.873% |
| iShares S&P 500 | 2.063% | 6.180% |
Comments by Guggenheim for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for BMY provided by MarketBeat
Stopped prediction by Guggenheim for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€49.69
08.04.26
08.04.26
€61.69
08.04.27
08.04.27
2.96%
25.05.26
25.05.26
